Insight Molecular Diagnostics Inc. — Director's Dealing 2020

Dec 17, 2020

SEC Form 4/A — Form 4/A

Issuer: OncoCyte Corp (OCX)
CIK: 0001642380
Period of Report: 2019-09-12

Reporting Person: Levine Mitchell S (CFO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2019-09-12	Common Stock	P	10000	$2.006	Acquired	13495	Direct

Footnotes

F1: The price of $2.006 per share represents a weighted average of prices ranging from $2.003 to $2.006 per share. The Reporting Person undertakes to provide upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares purchased or sold at each separate price.

F2: This Form 4 is being filed to amend the prior Form 4 filed by the Reporting Person on September 12, 2019, which erroneously did not combine the shares of common stock acquired by the Reporting Person on September 12, 2019 with the Reporting Person's common stock reported on his Form 4 on July 31, 2018.